Market signals

What's moving in financial services.

A monthly read on transformation activity, AI capability, benchmarks and regulation across the sector, alongside the filings calendar and cost ratios.

This is a curated public view. The horizon scan behind the platform runs continuously across a far wider source base and feeds the lever library directly — this page is a small window onto it.

REFRESHED MONTHLY LAST UPDATED · 1 SEP 2026 NEXT · 1 OCT 2026
HOW A SIGNAL REACHES YOUR DIAGNOSTIC
01 · SIGNAL OBSERVED
A peer discloses a post-deployment result, a vendor ships a capability, or a regulator sets a deadline.
02 · LEVER AFFECTED
The scan maps it to the levers and cost pools it bears on, or adds a lever the library did not hold.
03 · ASSUMPTION UPDATED
Benchmark ranges and default assumptions move, with the new source recorded against them.
04 · YOUR NEXT RUN
The next diagnostic reflects it. Rerun a saved version and see what changed, and why.
Filings & strategy calendar Cost-to-income tracker Transformation activity Benchmarks & stated impacts AI in financial services Regulation & policy watch
01 · Calendar

Next filings and strategy updates.

When the public record next changes. Results, capital markets days and strategy updates across the institutions the scan covers. Dates are as announced by the issuer and can move.

DATEINSTITUTION & EVENTTYPE
— —QUARTERLY/9M
— —HALF-YEAR RESULTS
15 SEP
Date as published by the issuer.
STRATEGY DAY
21 SEPSTRATEGY DAY / CMD
21 SEPSTRATEGY DAY
25 SEPDIVIDEND (NOT RESULTS)
1 OCTANALYST CALL (PRE-RESULTS)
7 OCT
Date as published by the issuer.
EGM
20 OCTQUARTERLY
21 OCTQUARTERLY (CALL)
22 OCT
Date described by the issuer as provisional and subject to change.
QUARTERLY
22 OCT
Date as published by the issuer.
QUARTERLY TRADING UPDATE
27 OCT
Date as published by the issuer.
QUARTERLY
27 OCT
Date as published by the issuer.
QUARTERLY REVENUE
28 OCT
Date as published by the issuer.
QUARTERLY
28 OCTQUARTERLY
28 OCT
Date as published by the issuer.
QUARTERLY/9M
28 OCT
Date as published by the issuer.
QUARTERLY TRADING UPDATE
29 OCT
Date as published by the issuer.
QUARTERLY
29 OCTIMS/QUARTERLY
29 OCT
Date as published by the issuer.
QUARTERLY/9M
29 OCT
Date as published by the issuer.
9M ACTIVITY INDICATORS
30 OCT
Date as published by the issuer.
QUARTERLY
30 OCT
Date as published by the issuer.
QUARTERLY
5 NOV
Date as published by the issuer.
QUARTERLY/9M
12 NOV
Date described by the issuer as provisional and subject to change.
BOARD MEETING
13 NOV
Date described by the issuer as provisional and subject to change.
QUARTERLY/9M
13 NOV
Date described by the issuer as provisional and subject to change.
QUARTERLY TRADING UPDATE
18 NOV
Date described by the issuer as provisional and subject to change.
STRATEGY DAY / INVESTOR DAY
~12–13 Nov 2026
Date described by the issuer as provisional and subject to change.
QUARTERLY/9M
~2026-10-22
Date described by the issuer as provisional and subject to change.
QUARTERLY TRADING UPDATE
~2026-10-29
Date described by the issuer as provisional and subject to change.
QUARTERLY/9M
~2026-10-29
Date described by the issuer as provisional and subject to change.
QUARTERLY INTERIM REPORT
~2026-11-11
Date described by the issuer as provisional and subject to change.
9M UPDATE
~late Oct 2026
Date described by the issuer as provisional and subject to change.
QUARTERLY
~late Oct 2026
Date described by the issuer as provisional and subject to change.
QUARTERLY
~late Oct/early Nov 2026
Date described by the issuer as provisional and subject to change.
QUARTERLY/9M

Event dates are published by the issuers themselves and are reproduced here as factual calendar information, with a link to the issuer's own announcement.

02 · Tracker

Cost-to-income, by archetype.

Cost ratios are not comparable across archetypes, so they are banded rather than ranked. Each band shows the median and the interquartile range across a defined constituent set, with movement since the prior reporting period.

ARCHETYPECONSTITUENTSMEDIANIQ RANGEMOVEMENT
Universal banks
Cost-to-income ratio, group level
10 reported54.4%35.9–70.0%-3.3 pts
Retail & specialist lenders
Cost-to-income ratio, group level
4 reported, 1 pending45.2%39.6–50.4%-2.8 pts
Insurers
Expense ratio, not directly comparable to CIR
5 reported91.5%60.4–93.3%+0.1 pts
Asset & wealth managers
Cost-to-revenue ratio
3 reported, 2 pending57.2%48.9–68.0%-3.5 pts
Payments & infrastructure
Cost-to-revenue ratio
3 reported, 2 pending50.1%50.0–52.7%+1.6 pts
Largest movements, last reported
IMPROVED
59% → 54% (Q2 cost:income ratio); H1 not captured · Q2 2026 standalone · statutory
-5.0 pts
54.7% → 50.4% (H1) / 49.0% (Q2) (cost:income ratio, underlying) · H1 2026 · underlying
-4.3 pts
63.8% → 59.7% (H1) / 58.6% (Q2) · H1 2026 and Q2 2026 standalone · statutory
-4.1 pts
DETERIORATED
49.5% → 52.7% (adjusted EBITDA margin) · H1 2026 · underlying
+3.2 pts
91.0% (+0.5pp) → 91.5% (P&C combined ratio; undiscounted 93.8%) · H1 2026 · statutory
+0.5 pts
92.4% (combined ratio); 30.0% (expense ratio) → 92.7% (P&C combined ratio); expense ratio 30.6% · H1 2026 · statutory
+0.3 pts

All ratios are as reported by the institution in its own published results, as at the date shown. Frontara does not restate, adjust or estimate these figures. Movements are the difference between two figures the institution itself published, on the same basis. Constituent sets and the reporting date for each band are stated at each refresh so the medians can be checked against the source filings.

03 · Activity

Transformation activity in the sector.

Announced programmes, restructurings, cost targets, operating model changes and appointments into transformation roles. These are the signals that shape a diagnostic before any number is sized.

27 AUG
Record H1 net profit (SFr673m); results centred on underwriting and capital strength, no new restructuring announced.
N/A — NO PROGRAMME ANNOUNCED
14 AUG
HY results framed continued transformation through AI: faster medical-underwriting reviews and automated QA, with a virtual assistant and AI-enabled claims agent to roll out.
OPERATIONS / TECHNOLOGY
13 AUG
H1 results: closed Talon.One and Orb acquisitions and disclosed Adyen Agentic (AI-agent payments) and Intelligent Money Movement, widening beyond core processing.
TECHNOLOGY / DISTRIBUTION
4 AUG
Interim results reaffirmed organisational simplification: $0.3bn H1 restructuring costs ($0.2bn in Q2, down $0.3bn on 1H25), saves offsetting inflation and tech spend; cost-efficiency ratio 46.2% (from 49.9%).
CORPORATE / OPERATIONS / TECHNOLOGY
04 · Benchmarks

Impacts institutions have stated themselves.

Cost targets, savings figures and efficiency outcomes announced publicly by the institutions themselves. Every figure here is one the company put on the record, attributed and linked.

13 AUG
Figure: Net revenue €1,302.9m, up 19% (21% constant currency); processed volume €803.8bn (+24%); EBITDA €641.5m at 49% margin (50% ex one-time costs). baseline vs H1 2025. by H1 2026. As stated by the institution.
REALISED
13 AUG
Figure: Customer conversion up 0.9 percentage points on average by end-H1 (via Adyen Uplift / Dynamic Identification). by H1 2026. As stated by the institution.
REALISED
13 AUG
Figure: FY net-revenue growth guidance raised to 21–23% (constant currency). baseline prior 20–22%. by FY2026. As stated by the institution.
TARGET
4 AUG
Figure: Operating-expense growth of approximately 1% for 2026 (target basis; excludes notable items, includes simplification saves). baseline vs 2025. by FY2026. As stated by the institution.
TARGET
4 AUG
Figure: Cost-efficiency ratio of 46.2%. baseline vs 49.9% (1H25). by H1 2026. As stated by the institution.
REALISED
4 AUG
Figure: RoTE of 17% or better for 2026, 2027 and 2028 (ex-notable items). by 2026–2028. As stated by the institution.
TARGET
4 AUG
Figure: H1 restructuring costs of $0.3bn tied to organisational simplification. baseline $0.3bn lower than 1H25. by H1 2026. As stated by the institution.
REALISED
WHAT IS NOT ON THIS PAGE
Frontara does not publish its own estimates, projections or sized opportunities for any named institution. Everything in this section is a figure the company itself disclosed. Derived analysis stays inside the platform, where the person running it controls the assumptions.
05 · AI

AI in financial services.

Vendors and startups building for the sector: what shipped, what was funded, what has been deployed, and what results have actually been disclosed. This feeds the AI half of the lever library.

~2026-08-28
$2.5m pre-seed led by Balderton Capital for an AI platform helping investment teams scale portfolio research and management; early-stage, no named client. Bears on operations. Results disclosed by Trade press (FinTech Global).
FUNDING
~2026-08-21
€150m ($175m) investment led by PIMCO into payment-acceptance technology provider serving banks, acquirers and fintechs; payments incumbent, not an AI pure-play. Bears on technology (payments infra). Results disclosed by Trade press (FinTech Global).
FUNDING
26 AUG
$6m seed led by Lux Capital for agent harnesses, an AI operating layer inside asset managers' systems for research and monitoring; US-centric, no named European client. Bears on operations / distribution. Results disclosed by Trade press (Finextra; BusinessWire).
FUNDING
25 AUG
Launched Gemini Enterprise for Financial Services, a governed agentic banking platform in preview (50+ new skills, 13 data connectors); Deutsche Bank is a key design partner for the Financial Research agent; vendor also cites CME Group, BNY, Citi Wealth, Lloyds Banking Group, Macquarie and Signal Iduna. Bears on operations / technology / distribution. Results disclosed by Vendor claim only ('under five minutes' bond-portfolio risk analysis); no bank-verified metric.
LAUNCH
5 AUG
Strategic partnership to build European-governed AI applications focused on cybersecurity and compliance; follows Mistral deals with BNP Paribas and HSBC. Bears on risk & compliance / technology. Results disclosed by No metric; terms undisclosed (bank release).
DEPLOYMENT

Vendors are listed because they appear in the scan, not because of any commercial relationship. Frontara takes no fee for inclusion.

06 · Policy

Regulation and policy watch.

Regulation moves cost pools directly, and it is rarely covered from a cost-base angle. Tracked here for what it does to compliance, technology and operations spend, and to the deadlines that constrain a roadmap.

~2026-08-26
Draft RTS on operational risk under Article 323(2) CRR3 (EBA/CP/2026/18), permitting reliance on DORA controls that meet the same requirement; virtual public hearing 29 Sep 2026. Compliance deadline: Consultation to 31 Dec 2026. Affects risk & compliance / operations.
RULEMAKING
25 AUG
Consultation EBA/CP/2026/17 on draft RTS for reclassification of investment firms as credit institutions under CRD IV. Compliance deadline: Consultation period per CP. Affects risk & compliance / corporate.
RULEMAKING
13 AUG
PS26/17 finalises targeted amendments to liquidity risk management for UCITS and NURS, aligned to FSB (2023) and IOSCO (May 2025) recommendations. Compliance deadline: Per PS26/17. Affects risk & compliance / operations.
RULEMAKING
13 AUG
Blog update on firms' readiness for the UK move to T+1 securities settlement. Compliance deadline: T+1 go-live 11 Oct 2027. Affects operations / technology.
RULEMAKING
5 AUG
Published minutes of its 3 June 2026 AI Consortium meeting (four workshops; human-in-the-loop limits, AI incident-reporting standardisation, agentic payments); not a rule. Compliance deadline: None. Affects risk & compliance / technology.
RULEMAKING
2 AUG
High-risk AI obligations fully enforceable: Annex III 5(b) covers creditworthiness/credit scoring and life & health insurance risk pricing (fraud detection carved out); full duties apply to newly deployed systems; high-risk fines up to €15m or 3% of global annual turnover (€35m/7% for prohibited practices). Compliance deadline: In force 2 Aug 2026; legacy systems generally to Feb 2027 — see review flag on possible Digital Omnibus delay. Affects risk & compliance / technology / operations.
RULEMAKING

Summaries are general information about published regulation and are not legal or compliance advice.

Sources and rights

Every item on this page links to its original source. Headlines and summaries are written in our own words; article text is not reproduced. Where a short extract is used it is attributed to the publisher. Copyright in the underlying material remains with its owner, and nothing here is intended to substitute for reading the original.

Company names, logos and trade marks belong to their respective owners and appear here for identification only. Reference to an institution or vendor does not imply any relationship with, or endorsement by, Frontara.

If you are a rights holder and believe something on this page should be removed or corrected, contact us and we will act promptly.

How to read this page

The scan refreshes on the first of each month. Sections driven by news and policy change every refresh. Cost ratios only move when institutions report, so each band carries the date it was last reported rather than the date of the refresh.

Nothing on this page is investment, legal or accounting advice, or a recommendation regarding any security. Figures are as reported by third parties and have not been independently verified by Frontara.

Event dates are set by issuers and can change without notice. Confirm against the issuer's own investor relations calendar before relying on them.

This is the scan. The diagnostic is what it feeds.

Tell us what you want to diagnose. We'll show you the platform, understand your objectives and discuss the scope and timing of your diagnostic.

Book an introductory call
FRONTARAAI
Outside-in value creation
diagnostics for financial services.
Built by transformation practitioners with experience delivering banking transformations at scale.
PLATFORM
Method Evidence Sample diagnostic Security
SOLUTIONS
Financial institutions Private equity
INSIGHTS
Market signals Contact
LEGAL
Privacy policy Terms of use Cookies
SOURCES
Frontara starts from publicly available data and information. Estimates are insight-based and cited.